DiaMedica Therapeutics
DMAC
DMAC
34 hedge funds and large institutions have $10M invested in DiaMedica Therapeutics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $14.9M → $10M (-$4.88M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
34
Holding in Top 10
–
Calls
$157K
Puts
$87K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$115K | |
| 3 | +$30.4K | |
| 4 |
Morgan Stanley
New York
|
+$23.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.7K |
Top Sellers
| 1 | -$540K | |
| 2 | -$485K | |
| 3 | -$227K | |
| 4 |
Two Sigma Advisers
New York
|
-$144K |
| 5 |
Millennium Management
New York
|
-$83K |